Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Management paradigms for metastatic castration-sensitive prostate cancer

How does the clinician use quality of life data to decide between chemotherapy and hormonal therapy?

Date

16 Oct 2020

Session

Management paradigms for metastatic castration-sensitive prostate cancer

Presenters

Alicia Morgans

Authors

A.K. Morgans

Author affiliations

  • Medicine, Northwestern University Feinberg School of Medicine, 60611 - Chicago/US
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings